Safety and Efficacy Study of rEV131 in the Treatment of Ocular Inflammation After Cataract Surgery
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of three concentrations
of rEV131, a new investigational anti-inflammatory agent, compared to placebo (an inactive
substance) and an FDA approved anti-inflammatory agent in patients with ocular inflammation
who have undergone cataract extraction with intra-ocular lens implantation.